Prosecution Insights
Last updated: October 02, 2026
Application No. 17/616,220

COCOA EXTRACTION METHODS AND TECHNIQUES

Final Rejection §103
Filed
Dec 03, 2021
Priority
Jun 04, 2019 — EU 19178069.1 +1 more
Examiner
ZILBERING, ASSAF
Art Unit
1792
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Odc Lizenz AG
OA Round
5 (Final)
35%
Grant Probability
At Risk
6-7
OA Rounds
0m
Est. Remaining
63%
With Interview

Examiner Intelligence

Grants only 35% of cases
35%
Career Allowance Rate
232 granted / 659 resolved
-29.8% vs TC avg
Strong +28% interview lift
Without
With
+27.8%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
49 currently pending
Career history
717
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
63.5%
+23.5% vs TC avg
§102
7.9%
-32.1% vs TC avg
§112
22.3%
-17.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 659 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Status of Claims Note: The amendment of April 14th 2026 has been considered. Claims 1-20 are pending in the current application. Claims 1-12 and 14-20 are withdrawn from consideration. Claim 13 is examined in the current application. Any rejections not recited below have been withdrawn. Claim Rejections - 35 USC § 103 The text of those sections of Title 35 of the U.S. Code not included in this action can be found in a prior Office action. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim 13 stands rejected under 35 U.S.C. 103 as being unpatentable over Hühn (EP 3114942 B1) in view of Hammerstone Jr. et al., (US 6,627,232). Regarding claim 13: Hühn discloses cocoa beans extracts with high content of polyphenols, antioxidants, vitamins and/or sugars, wherein the nibs are not fermented or pre-dried prior to extraction (see Hühn paragraphs [0001] and [0012]-[0014]). Furthermore, Hühn discloses the extraction process temperature is below 70°C and comprises first forming a suspension of cocoa nibs in an aqueous ethanol solution (i.e., a mixture of a first extraction agent, water and ethanol) comprising 1-90wt% ethanol, followed by wet grinding and separating the ground suspension into three phases, water, fat (i.e., cocoa butter) and solids, followed by further processing the phases to attain cocoa butter, cocoa powder, polyphenolic powder and cocoa aroma extracts (see Hühn paragraphs [0012]-[0014], [0029], [0033] and [0043]-[0044]), but fails to disclose an organic solvent; However, Hammerstone discloses extracting cocoa butter, aroma and other compounds from cocoa nibs using a 50:50 mixture of water and acetone as such mixture provides better separation than provided by a water and ethanol solution (see Hammerstone abstract; from column 3, line 43 to column 5, line 39). Accordingly, it would have been obvious to a skilled artisan at the time the application was filed to have modified Hühn and to have used a 50:50 water:acetone extraction solution, to attain improved separation, and thus arrive at the claimed limitations. In the alternative, even though Hühn in view of Hammerstone may fail to disclose every step of the claimed process of extracting the cocoa nibs, it is noted that the recited cocoa nibs extract product is limited and defined by process limitations, as such, the patentability of the coca beans extract product and not the recited process steps of claim 13 must be established. As set forth in MPEP §2113, “even though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process.” In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985). In this case, Hühn discloses cocoa beans extracts with high content of polyphenols, antioxidants, vitamins and/or sugars, wherein such productions are known to involve extraction methods using low temperature processes and solvents, the cocoa beans extracts in Hühn in view of Hammerstone reasonably appears to be either identical or similar to the cocoa beans extracts recited in the claims, and thus Hühn in view of Hammerstone meets the claim limitations. Otherwise, any slight differences in the composition as a result of the recited process steps would have been obvious to one of ordinary skill in the art and well within the ordinary level of skill to have produced. Modifications to a well-established process that are minor is considered well within the realm of ordinary skill. Response to Arguments Applicant's arguments filed on April 14th 2026 have been fully considered but they are not persuasive. Applicant argues on pages 3-4 of the “Remarks” the prior art references fail to render the claimed invention obvious, because the cocoa beans in Hühn and in Hühn as modified by Hammerstone are processed through processes that differ from the process recited in the product-by-method claim 13 claiming the cocoa bean extract, as Hühn discloses a temperature controlled dry grinding of the nibs and Hammerstone discusses extractions using different organic solvents of processed nibs, which is different than the wet grinding and organic extraction unprocessed nibs recited in claim 13 and contemplated by Applicant in the specification. The examiner respectfully disagrees. As discussed above, while Hühn in view of Hammerstone may fail to disclose every step of the claimed process of extracting the cocoa nibs, it is noted that the recited cocoa nibs extract product is limited and defined by process limitations, as such, the patentability of the coca beans extract product and not the recited process steps of claim 13 must be established. As set forth in MPEP §2113, “even though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process.” In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985). In this case, Hühn discloses cocoa beans extracts with high content of polyphenols, antioxidants, vitamins and/or sugars, wherein such productions are known to involve extraction methods using low temperature processes and solvents, the cocoa beans extracts in Hühn in view of Hammerstone reasonably appears to be either identical or similar to the cocoa beans extracts recited in the claims, and thus Hühn in view of Hammerstone meets the claim limitations. Applicant argues on page 4 that the prior art references fail to render the claimed invention obvious, because Hühn modified by Hammerstone, at most, teaches a method where the three-phase separation would be attained by using ethyl acetate and acetone/ethanol as the solvents, which would provide extracts different from the extracts produced by the steps of claim 13, as the majority of the polyphenols would have been already removed via the aqueous phase as disclosed in Hühn. The examiner respectfully disagrees. The Hühn in view of Hammerstone would not only teach attaining the three-phase separation using ethyl acetate and acetone/ethanol as the solvents. Instead, since Hammerstone discloses embodiments of serial extractions to selectively attain higher or lower molecular weight cocoa procyanidin oligomers from cocoa beans, Hammerstone also discloses in column 4 lines 15-59, that the organic solvents used may be aqueous ethanol and/or aqueous acetone and that the choice of solvent allows for different process parameters (e.g., temperature) and extracted product. Accordingly, Hühn modified by Hammerstone also teaches substituting the aqueous ethanol from Hühn with the aqueous acetone from Hammerstone to attain desire product. Moreover, as to prior art combination teaching the majority of the polyphenols are present in the aqueous phase, which is different than the extract produced by the claimed method, it is noted that claim 13 recites the polyphenols are in the first liquid phase. Since claim 13 recites the cocoa butter is in the second liquid phase (i.e., the hydrophobic phase), the first liquid phase in claim 13 is the aqueous phase, which also comprises polyphenols according to the claim language. Finally, the assertion that the method of the prior art combination provides extracts that are different than the extracts attained by the claimed method is not persuasive, because Applicant fails to provide evidence supporting that assertion. Applicant argues on pages 4-5 of the “Remarks” that the prior art references fail to render the claimed invention obvious, because substituting the aqueous ethanol from Hühn with the aqueous acetone from Hammerstone would render different extracted product, and Hammerstone contemplates serial extraction steps with the aqueous acetone extraction as one of the steps, which would render a different product than the claimed product. The examiner respectfully disagrees. To clarify, while Hammerstone discloses embodiments of serial extractions to selectively attain higher or lower molecular weight cocoa procyanidin oligomers from cocoa beans, Hammerstone also discloses in column 4 lines 15-59, that the organic solvents used may be aqueous ethanol and/or aqueous acetone and that the choice of solvent allows for different process parameters (e.g., temperature) and extracted product. Accordingly, it would have been obvious to a skilled artisan to substitute the aqueous ethanol from Hühn with the aqueous acetone from Hammerstone to attain desire product. Moreover, it is noted that while Hühn does not disclose all the features of the present claimed invention, Hammerstone is used as a teaching reference, and therefore, it is not necessary for these secondary reference to contain all the features of the presently claimed invention, In re Nievelt, 482 F.2d 965, 179 USPQ 224, 226 (CCPA 1973), In re Keller 624 F.2d 413, 208 USPQ 871, 881 (CCPA 1981). Rather, Hammerstone teaches that aqueous ethanol and aqueous acetone provide selective cocoa extracts with high molecular weight oligomers, and that cocoa extractions with aqueous ethanol are carried out at 20°C-50°C and that cocoa extraction with aqueous acetone are carried out at 50°C-boiling point of mixture, thus in combination with Hammerstone (i.e., teaching reference), Hühn discloses the presently claimed invention. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ASSAF ZILBERING whose telephone number is (571)270-3029. The examiner can normally be reached M-F 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Erik Kashnikow can be reached at (571) 270-3475. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ASSAF ZILBERING/Examiner, Art Unit 1792 /ERIK KASHNIKOW/Supervisory Patent Examiner, Art Unit 1792
Read full office action

Prosecution Timeline

Show 6 earlier events
Aug 28, 2025
Request for Continued Examination
Sep 02, 2025
Response after Non-Final Action
Oct 02, 2025
Non-Final Rejection mailed — §103
Oct 28, 2025
Interview Requested
Dec 19, 2025
Response Filed
Jan 14, 2026
Non-Final Rejection mailed — §103
Apr 14, 2026
Response Filed
Sep 04, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12745786
Compositions with novel cannabinoid and terpene profiles
5y 3m to grant Granted Sep 29, 2026
Patent 12745782
OIL/FAT COMPOSITION
3y 0m to grant Granted Sep 29, 2026
Patent 12740575
Method Of Efficiently Separating Solid Fat From Polyunsaturated Fatty Acid Grease
3y 3m to grant Granted Sep 22, 2026
Patent 12696909
A VEGETABLE FAT COMPOSITION COMPRISING C14 FATTY ACIDS AND OTHER SATURATED FATTY ACIDS
3y 5m to grant Granted Aug 04, 2026
Patent 12672658
OIL-AND-FAT COMPOSITION
5y 5m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

6-7
Expected OA Rounds
35%
Grant Probability
63%
With Interview (+27.8%)
4y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 659 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month